T
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Price:
4 933 ILS
0.98%
Market Closed
Updated:
Apr 28, 2024
Teva Pharmaceutical Industries Ltd
Operating Income
|
Teva Pharmaceutical Industries Ltd
Operating Income Peer Comparison
Comparables:
TARO
I
INCR
MDWD
R
REKA
C
CSURE
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
T
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Operating Income
$3.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-1%
|
|
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Operating Income
$22m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
-25%
|
|
I
|
InterCure Ltd
TASE:INCR
|
Operating Income
₪40m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mediwound Ltd
NASDAQ:MDWD
|
Operating Income
-$15.5m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-7%
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Operating Income
₪5.6m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-10%
|
|
C
|
Cannassure Therapeutics Ltd
TASE:CSURE
|
Operating Income
-₪2.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Teva Pharmaceutical Industries Ltd's Operating Income?
Operating Income
3.5B
USD
3.5B
USD
Based on the financial report for Dec 31, 2023, Teva Pharmaceutical Industries Ltd's Operating Income amounts to 3.5B USD.
What is Teva Pharmaceutical Industries Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
-1%
-1%
Over the last year, the Operating Income growth was 11%. The average annual Operating Income growth rates for Teva Pharmaceutical Industries Ltd have been 4% over the past three years , 2% over the past five years , and -1% over the past ten years .
You don't have any saved screeners yet
